$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Cannabinod formulation for the sedation of a human or animal

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/352
  • A61K-045/06
출원번호 US-0820507 (2015-08-06)
등록번호 US-9585867 (2017-03-07)
발명자 / 주소
  • Ankner, Charles Everett
출원인 / 주소
  • Ankner, Charles Everett
대리인 / 주소
    The Roy Gross Law Firm, LLC
인용정보 피인용 횟수 : 0  인용 특허 : 147

초록

A method of humanely incapacitating or immobilizing a human or animal by providing a formulation including a cannabinoid rendering a recipient incapacitated or immobilized within a short period of time, and a delivery system which doses the recipient with the formulation resulting in a tetrahydrocan

대표청구항

1. A method of humanely incapacitating a human or animal, the method comprising the steps of: providing a formulation including a cannabinoid;providing a delivery system comprising an injection step for dosing the recipient with the cannabinoid formulation resulting in a tetrahydrocannabinol blood l

이 특허에 인용된 특허 (147)

  1. Lippa,Arnold Stan; Epstein,Joseph William, (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor.
  2. Burstein Sumner H. (6 Knight Rd. Framingham MA 01701) Mechoulam Raphael (Jerusalem ILX), (3R,4R)-D6-tetrahydrocannabinol-7-oic acids useful as antiinflammatory agents an.
  3. Mechoulam Raphael (Jerusalem ILX) Breuer Aviva (Jerusalem ILX) Devane William (Jerusalem ILX) Burstein Sumner H. (Framingham MA), (3S,4S)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processors for their preparation and pharmaceu.
  4. Mechoulam Raphael (Jerusalem ILX) Feigenbaum Jeffery J. (Jerusalem ILX) Lander Naphtali (Tel-Aviv IN ILX) Srebnik Morris (Lafayette IN), (3S-4S)-7-hydroxy-D6-tetrahydrocannabinols.
  5. Hallahan,David L.; Coldren,Christopher; Flint,Dennis; Wang,Hong, -prenyltransferases from plants.
  6. Peart, Joanne; Byron, Peter R.; Lichtman, Aron H.; Martin, Billy R., .DELTA.9 Tetrahydrocannabinol (.DELTA.9 THC) solution metered dose inhaler.
  7. Lochead Alistair,FRX ; Jegham Samir,FRX ; Galli Frederic,FRX ; Gallet Thierry,FRX, 2,3-dihydrofuro [3,2-.beta.]pyridin, preparation and application thereof in therapy.
  8. John A. Lowe, III, 2-aminopyridines containing fused ring substituents.
  9. Mechoulam, Raphael; Gallily, Ruth; Breuer, Aviva; Shohami, Esther; Panikashvili, David, 2-arachidonylglycerol (2-AG)-an inhibitor of tumor necrosis factor-α and neuroprotector of brain in closed head injury.
  10. Achard, Daniel; Bouchard, Herv?; Bouquerel, Jean; Capet, Marc; Grisoni, Serg; Malleron, Jean-Luc; Mignani, Serge; Hittinger, Augustin, Acetindine derivatives, their preparation and medicaments containing them.
  11. Hale, Ron L.; Lei, Mingzu; Lloyd, Peter M.; Munzar, Patrik; Sharma, Krishnamohan; Solas, Dennis W.; Stracker, Matthew D., Aerosol drug delivery device incorporating percussively activated heat packages.
  12. Fride, Ester; Breuer, Aviva; Hanus, Lumir; Tchilibon, Susanna; Horowitz, Michal; Mechoulam, Raphael; Garzon, Aaron, Agonists specific for the peripheral cannabinoid receptor.
  13. Fride, Ester; Breuer, Aviva; Hanus, Lumir; Tchilibon, Susanna; Horowitz, Michal; Mechoulam, Raphael; Garzon, Aaron, Agonists specific for the peripheral cannabinoid receptor.
  14. Fride,Ester; Breuer,Aviva; Hanus,Lumir; Tchilibon,Susanna; Horowitz,Michal; Mechoulam,Raphael; Garzon,Aaron, Agonists specific for the peripheral cannabinoid receptor.
  15. Roques, Bernard; Fournie-Zaluski, Marie-Claude, Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase N inhibitors.
  16. Macy, Omar Alonso; Pham, Loc T., Ammunition magazine having two or more supply ports.
  17. Goodchild, Juliet Marguerite; Goodchild, Colin Stanley; Boyd, Benjamin James, Anaesthetic formulation.
  18. Mechoulam, Raphael; Parker, Linda; Breuer, Aviva, Anti-nausea and anti-vomiting activity of cannabidiol compounds.
  19. Mechoulam Raphael (Jerusalem ILX) Abrahamov Abraham (Jerusalem ILX), Antiemetic compositions.
  20. Page, Jonathan E.; Boubakir, Zakia, Aromatic prenyltransferase from Cannabis .
  21. Mittendorf Joachim,DEX ; Dressel Jurgen,DEX ; Matzke Michael,DEX ; Keldenich Jorg,DEX ; Mohrs Klaus-Helmut,DEX ; Raddatz Siegfried,DEX ; Franz Jurgen,DEX ; Spreyer Peter,DEX ; Vohringer Verena,DEX ; , Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases.
  22. Mittendorf, Joachim; Dressel, Jurgen; Matzke, Michael; Keldenich, Jorg; Mohrs, Klaus-Helmut; Raddatz, Siegfried; Franz, Jurgen; Spreyer, Peter; Vohringer, Verena; Schuhmacher, Joachim; Rock, Michael-, Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases.
  23. Mittendorf, Joachim; Dressel, Jurgen; Matzke, Michael; Keldenich, Jorg; Mauler, Frank; de Vry, Jean-Marie-Viktor; Franz, Jurgen; Spreyer, Peter; Vohringer, Verena; Schumacher, Joachim; Rock, Michael-, Aryl sulphonamide amino acid esters and analogues.
  24. Joachim Mittendorf DE; Jurgen Dressel DE; Michael Matzke DE; Jorg Keldenich DE; Frank Mauler DE; Jean-Marie-Victor de Vry DE; Jurgen Franz DE; Peter Spreyer DE; Verena Vohringer DE; Joachim , Aryl sulphonamides and analogues.
  25. Mechoulam, Raphael; Magid, Lital; Shohami, Esther; Bab, Itai, Arylated camphenes, processes for their preparation and uses thereof.
  26. Mittendorf, Joachim; Dressel, Jürgen; Matzke, Michael; Keldenich, Jörg; Mauler, Frank; de Vry, Jean-Marie-Victor; Franz, Jürgen; Spreyer, Peter; Vöhringer, Verena; Schumacher, Joa, Arylsulphonamides and analogues.
  27. Yu,Guixue; Ewing,William R.; Mikkilineni,Amarendra B.; Pendri,Annapurna; Sher,Philip M.; Gerritz,Samuel; Ellsworth,Bruce A.; Wu,Gang; Huang,Yanting; Sun,Chongqing; Murugesan,Natesan; Gu,Zhengxiang; Wang,Ying; Sitkoff,Doree; Johnson,Stephen R.; Wu,Ximao, Azabicyclic heterocycles as cannabinoid receptor modulators.
  28. Makriyannis, Alexandros; Vemuri, Venkata K, CB1 receptor antagonists and uses thereof.
  29. Stone, Sonya, Canna and Shea topical cream.
  30. Duchek,John Robert, Cannabinoid crystalline derivatives and process of cannabinoid purification.
  31. G. R. Barrie Webster CA; Leonard P. Sarna CA, Cannabinoid extraction method.
  32. Winnicki, Robert, Cannabinoid formulations.
  33. Brooke Lawrence L. ; Herrmann Cal C., Cannabinoid patch and method for cannabis transdermal delivery.
  34. Brooke Lawrence L. ; Herrmann Cal C. ; Yum Su IL, Cannabinoid patch and method for cannabis transdermal delivery.
  35. Guy, Geoffrey; Platt, Bettina, Cannabinoid-containing plant extracts as neuroprotective agents.
  36. Todd, William W., Cannabis drug delivery and monitoring system.
  37. Mechoulam Raphael (Jerusalem ILX) Breuer Aviva (Jerusalem ILX) Devane William (Jerusalem ILX) Burstein Sumner H. (Framingham MA), Certain tetrahydrocannabinol-7-oic acid derivatives.
  38. Van Damme, Philippus Anne; Anastassov, George Evgeniyevich, Chewing gum compositions comprising cannabinoids.
  39. Hallahan, David L.; Coldren, Christopher; Flint, Dennis; Wang, Hong, Cis-prenyltransferases from plants.
  40. McPhillips, Andrea M; Economou, Julia J; Dedhiya, Mahendra G; Wynne, Beverly Ann, Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent.
  41. McDowell, Jr., John W., Compositions and methods for treating prostate disorders.
  42. Gonzales, Gilbert R.; Jennings, Thomas P.; Schellenger, Norman D., Compositions and methods for treating upper respiratory congestion.
  43. Whittle, Brian; Javid, Farideh Afshin, Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions.
  44. Balwani, Gul; Sacks, Harry J.; Roecklein, Bryan A.; Johns, Benjamin, Compositions comprising carisoprodol and methods of use thereof.
  45. Mechoulam, Raphael; Kogan, Natalya M.; Rabinowitz, Ruth; Schlesinger, Michael, Compositions including quinonoid derivatives of cannabinoids for therapeutic use.
  46. Castelhano, Arlindo L.; McKibben, Bryan; Witter, David J., Compounds specific to adenosine A1 receptor and uses thereof.
  47. Hospodor, Andrew David, Controlled Cannabis decarboxylation.
  48. Webster,G. R. Barrie; Sarna,Leonard P.; Mechoulam,Raphael, Conversion of CBD to Δ-THC and Δ-THC.
  49. Rastegar,Jahangir S., Deployable bullets.
  50. Rastegar,Jahangir S., Deployable bullets having a tranquilizer.
  51. Rastegar,Jahangir S., Deployable bullets having high voltage electrodes.
  52. Takkinen, Kristiina; Söderlund, Hans; Pulli, Timo, Detection of cannabis use.
  53. Leone-Bay, Andrea; Moye-Sherman, Destardi; Wilson, Bryan R., Diketopiperazine salts for drug delivery and related methods.
  54. Chen, Feng-Jing; Patel, Mahesh V., Emulsion compositions for polyfunctional active ingredients.
  55. Putman, David; Hogenkamp, Derk; Dasse, Olivier; Whittemore, Edward R.; Jensen, Mark S., Enantiomerically pure S-etifoxine, pharmaceutical compositions thereof and methods of their use.
  56. Whittle,Brian; Hill,Colin A.; Flockhart,Ian R.; Downs,David Victor; Gibson,Peter; Wheatley,Gary William, Extraction of pharmaceutically active components from plant materials.
  57. Mechoulam, Raphael; Bab, Itai; Milman, Gary; Smoum, Reem, Fatty acid amides and uses thereof.
  58. Mechoulam Raphael (Jerusalem ILX) Beuer Aviva (Jerusalem ILX) Hanus Lemir (Jerusalem ILX) Devane William A. (Chevy Chase MD), Fatty acid derivatives and pharmaceutical compositions containing same.
  59. Thompson,Diane O.; Mosher,Gerold L., Formulations containing propofol and a sulfoalkyl ether cyclodextrin.
  60. Bell,Alan R.; Cochrane,Fenella; O'Connor,Geoffrey N.; Rowe,James S., Formulations for anaesthetic use.
  61. Kuliopulos, Athan; Covic, Lidija, G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same.
  62. Archer Robert A. (Indianapolis IN), Hexahydro-dibenzo[b,d]pyran-9-ones as sedative drugs.
  63. Park, Joon-Hyun; Apuya, Nestor; Bobzin, Steven Craig, Identification of terpenoid-biosynthesis related regulatory protein-regulatory region associations.
  64. Cook, Robert Owen; Armer, Thomas A, Inhalation devices and related methods for administration of sedative hypnotic compounds.
  65. Mishra,Awadhesh K.; Pace,Gary W.; Vachon,Michael G, Injectable aqueous dispersions of propofol.
  66. Santillan, Victor M.; Santillan, Monica, Liquid mixture and methods for use.
  67. Kolsky, Jeffrey A., Medical cannabis lozenges and compositions thereof.
  68. Pojer, Florence; Noel, Joseph P.; Larsen, Elise; Bowman, Marianne; Richard, Stephane, Metabolic engineering of lipid metabolism by improving fatty acid binding and transport.
  69. McKinney Laurence O. (881 Massachusetts Ave. Cambridge MA 02139), Method and apparatus for processing herbaceous plant materials including the plant cannabis.
  70. Guy, Geoffrey; Robson, Philip, Method for the treatment of constipation.
  71. Mitch Charles H. ; Sauerberg Per,DKX ; Shannon Harlan E., Method for treating schizophrenia.
  72. ElSohly Mahmoud A. (Oxford MS) Brenneisen Rudolf M. (Berne CHX), Method of identifying country of origin of cannabis.
  73. Bisterfeld Von Meer, Galathea U., Method of obtaining hemp plant juice and use of same for the production of beverages.
  74. Elsohly, Mahmoud A.; Ross, Samir A., Method of preparing delta-9-tetrahydrocannabinol.
  75. Mahmoud A. Elsohly ; Samir A. Ross, Method of preparing delta-9-tetrahydrocannabinol.
  76. Wallace, Walter H., Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment.
  77. Rosenblatt, Steven; Tucker, Jeffrey; DeAngelo, Steve, Methods and compositions of cannabis extracts.
  78. Bab, Itai; Mechoulam, Raphael; Zimmer, Andreas; Shohami, Esther, Methods compositions and articles of manufacture for modulating bone growth.
  79. Flockhart, Ian R.; Wheatley, Gary William; Dring, Su; Archer, Leslie, Methods of preparing cannabinoids from plant material.
  80. Flockhart, Ian; Wheatley, Gary William; Dring, Su; Archer, Lesley, Methods of purifying cannabinoids from plant material.
  81. Kloog Yoel (Hertzlyia IL ILX) Feigenbaum Jeffrey J. (Chicago IL) Mechoulam Raphael (Jerusalem ILX) Sokolovsky Mordechai (Tel Aviv ILX) Benita Simon (Mevasseret Zion ILX), NMDA-blocking pharmaceutical compositions.
  82. Mechoulam Raphael (Jerusalem ILX) Sokolovsky Mordechai (Tel Aviv ILX) Kloog Yoel (Hertzlyia ILX) Biegon Anat (Tel Aviv ILX), NMDA-blocking pharmaceuticals.
  83. Castor, Trevor Percival; Purdum, Geoffrey, Nanoencapsulated delta-9-tetrahydrocannabinol.
  84. Mechoulam Raphael (Jerusalem ILX) Breuer Aviva (Jerusalem ILX) Biegon Anat (Tel Aviv ILX), Neuroprotective pharmaceutical compositions of 4-phenylpinene derivatives and certain novel 4-phenylpinene compounds.
  85. Booth Anthony ; Dickstein Harvey ; Koup Jeffrey R., Non-sedating acrivastine product.
  86. Du, Jie, Non-sedating antihistamine injection formulations and methods of use thereof.
  87. A. K. Gunnar Aberg, Non-sedating diphenhydramine metabolites.
  88. Mechoulam Raphael (Jerusalem ILX) Lander Naphtali (Tel-Aviv ILX) Dikstein Shabtay (Jerusalem ILX) Shalita Benyamin (Jerusalem ILX), Novel tetrahydrocannabinol type compounds.
  89. Sandomirsky, Sergey; Esterkin, Vladimir; Forrester, Thomas C.; Jannson, Tomasz; Kostrzewski, Andrew; Naumov, Alexander; Ma, Naibing; Ro, Sookwang; Shnitser, Paul I., Optical impact control system.
  90. Cunningham, Scott D.; Ittel, Steven Dale; O'Brien, John P.; Rouviere, Pierre E., Peptides for binding calcium carbonates and methods of use.
  91. Speier, Gary J., Pharmaceutical composition and method of manufacturing.
  92. Lowenstein, William; Sanchez, Mario; Lepere-Prevot, Benedicte; De Rothschild, Benjamin, Pharmaceutical composition based on cocaethylene and use thereof for treating psychoactive substance dependence.
  93. Kelly, Brooks J., Pharmaceutical composition comprising Cannabinoids.
  94. Murty, Ram B.; Chowdhury, Dipak K.; Mangena, Murty, Pharmaceutical composition containing tetrahydrocannabinol and a transdermal/transcutaneous delivery method thereof.
  95. Ross, Calvin, Pharmaceutical compositions.
  96. Ross, Calvin, Pharmaceutical compositions.
  97. Musty, Richard E.; Deyo, Richard, Pharmaceutical compositions comprising cannabichromene type compounds.
  98. Mechoulam, Raphael; Tchilibon, Susana; Fride, Ester; Hanus, Lumir; Breuer, Aviva; Gallily, Ruth, Pharmaceutical compositions comprising cannabidiol derivatives.
  99. Mechoulam, Raphael; Fride, Ester, Pharmaceutical compositions containing (+) cannabidioil and derivatives thereof and some such novel derivatives.
  100. Achard, Daniel; Bouchard, Hervé; Bouquerel, Jean; Filoche, Bruno; Grisoni, Serge; Hittinger, Augustin; Myers, Michael R., Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation.
  101. Guy, Geoffrey; Robson, Philip, Pharmaceutical compositions for the treatment of pain.
  102. Whittle, Brian, Pharmaceutical formulation.
  103. Whittle, Brian, Pharmaceutical formulation.
  104. Whittle, Brian Anthony, Pharmaceutical formulation.
  105. Whittle, Brian Anthony, Pharmaceutical formulation.
  106. Whittle, Brian A.; Guy, Geoffrey W., Pharmaceutical formulations.
  107. Whittle,Brian A.; Guy,Geoffrey W., Pharmaceutical formulations.
  108. Quallich,George J.; Wint,Lewin T., Pharmaceutically acceptable salts of sertraline and pharmaceutical compositions thereof.
  109. Dolle, Roland E.; Worm, Karin; Zhou, Q. Jean, Phenyl derivatives and methods of use.
  110. Letzel, Heinz; Ebell, legal representative, Thomas; Klaeger, Regina; Klaeger, Rudolph, Plant extract from low-THC Cannabis for the treatment of disease.
  111. Razdan Raj Kumar (Belmont MA) Dalzell Haldean Cloyce (Weston MA), Process for the preparation of (-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-pyrans.
  112. Saikia Chowdhury Nath,INX ; Goswami Tridip,INX ; Ghosh Anil Chandra,INX, Process for the preparation of alkali salt of carboxy alkyl cellulose.
  113. Whittle, Brian; Guy, Geoffrey; Downs, David; Pate, David, Processes and apparatus for extraction of active substances and enriched extracts from natural products.
  114. Whittle, Brian; Guy, Geoffrey; Downs, David; Pate, David W., Processes and apparatus for extraction of active substances and enriched extracts from natural products.
  115. Stinchcomb, Audra Lynn; Golinski, Miroslaw Jerzy; Hammell, Dana Carmel; Howard, Jeffery Lynn, Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same.
  116. Stinchcomb, Audra Lynn; Golinski, Miroslaw Jerzy; Hammell, Dana Carmel; Howard, Jeffrey Lynn, Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same.
  117. Beasley ; Jr. Charles M. ; Chakrabarti Jiban Kumar,GB2 ; Hotten Terrence Michael,GB2 ; Tupper David Edward,GB2, Psychoactive substance disorders.
  118. Galli, Frederic; Jegham, Samir; Lochead, Alistair; Samson, Axelle, Pyridopyranoazepine derivatives, their preparation and their therapeutic application.
  119. Bright,Gene Michael; Brodney,Michael A.; Wlodecki,Bishop, Pyridyloxymethyl and benzisoxazole azabicyclic derivatives.
  120. Gooberman Lance L., Rapid opioid detoxification.
  121. De Meijer, Etienne, Reference plant, a method for its production, extracts obtained therefrom and their use.
  122. Feldman, Paul L.; Jung, David Kendall; Kaldor, Istvan; Pacofsky, Gregory J.; Stafford, Jeffrey A.; Tidwell, Jeffrey H., Short-acting benzodiazepines.
  123. Feldman,Paul L.; Jung,David Kendall; Kaldor,Istvan; Pacofsky,Gregory J.; Stafford,Jeffrey A.; Tidwell,Jeffrey H., Short-acting benzodiazepines.
  124. Enslin,George Frederick, Smoker's requisite.
  125. Patel, Mahesh V.; Chen, Feng-Jing, Solid carriers for improved delivery of active ingredients in pharmaceutical compositions.
  126. Patel, Mahesh V.; Chen, Feng-Jing, Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions.
  127. Pritchett, Graham Bryan, Sonically formed trichomic extract material.
  128. Ragner Gary Dean (3111 SW. 34th St. ; Lot 70 Gainesville FL 32608), Stun bullets.
  129. Dolle,Roland E.; Worm,Karin; Zhou,Q. Jean, Sulfamoyl benzamide derivatives and methods of their use.
  130. Dolle, Roland E.; Worm, Karin, Sulfamoyl benzamides and methods of their use.
  131. Pedersen Arne (Hinnerup DKX) Johannsen Frank (Viby J DKX), Surface treatment composition.
  132. Mechoulam, Raphael; Fride, Esther; Ben Shabat, Shimon; Sheskin, Tzviel; Breuer, Aviva, Synthetic endogenous cannabinoids analogues and uses thereof.
  133. Coles, Jr., Albert L, Systems and methods for producing organic cannabis tincture.
  134. Fliri, Anton Franz Joseph; Butler, Todd William; Gallaschun, Randall James; Ragan, John Anthony; Jones, Brian Patrick, Tetrahydroquinazoline-2,4-diones and therapeutic uses thereof.
  135. Williams, Simon F.; Martin, David P., Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate.
  136. McCook, John Patrick; Persaud, Indushekhar; Narain, Niven Rajin, Topical formulations having enhanced bioavailability.
  137. Patel Mahesh V. ; Chen Feng-Jing, Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents.
  138. Shohami Esther,ILX ; Gallily Ruth,ILX ; Mechoulam Raphael,ILX, Tumor necrosis factor .alpha. (TNF-.alpha.) inhibiting pharmaceuticals.
  139. Shohami Esther,ILX ; Gallily Ruth,ILX ; Mechoulam Raphael,ILX, Tumor necrosis factor alpha (TNF-.alpha.) inhibiting pharmaceuticals.
  140. Shohami, Esther; Gallily, Ruth; Mechoulam, Raphael, Tumor necrosis factor alpha (TNF-.alpha.) inhibiting pharmaceuticals.
  141. Marc Feldmann GB; Anne-Marie Malfait GB; Ruth Gallily IL; Raphael Mechoulam IL, Use of cannabinoids as anti-inflammatory agents.
  142. Kikuchi, Tetsuro; Maeda, Kenji; Guy, Geoffrey; Robson, Philip; Stott, Colin, Use of cannabinoids in combination with an anti-psychotic medicament.
  143. Whalley, Ben; Stephens, Gary; Williams, Claire; Guy, Geoffrey; Wright, Stephen; Kikuchi, Tetsuro, Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy.
  144. Saari Walfred S. (Lansdale PA) Huff Joel R. (Gwynedd PA), Use of piperazinyl-imidazo[1,2-a]pyrazines in sedation.
  145. Goodchild, Colin Stanley; Nadeson, Raymond, Use of pregnane-diones as analgesic agents.
  146. Ralph J. Lamson, Virtual reality immersion therapy for treating psychological, psychiatric, medical, educational and self-help problems.
  147. Peart, Joanne; Byron, Peter R.; Lichtman, Aron H.; Martin, Billy R., Δ9 tetrahydrocannabinol (Δ9 THC) solution metered dose inhalers and methods of use.

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트